$38,339,677
to THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND)
TO FUND THE PURCHASE OF LENACAPAVIR FOR PREP THROUGH WAMBO.ORG FOR DOS / GHSD-FINANCED BENEFICIARIES IN PEPFAR-SUPPORTED COUNTRIES.
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Purchase and distribute Lenacapavir HIV prevention medication in PEPFAR-supported developing countries.
Extends U.S. HIV prevention leadership while addressing disease in vulnerable developing-nation populations.
Increases demand for Lenacapavir production and pharmaceutical supply chains reaching developing countries.
U.S. health diplomacy competing with China's Belt and Road health initiatives in the developing world.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-14. Cost: $0.016718.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_SAQMIP26GR0017_019.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.